MedTrace Logo

Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19

NCT05188482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2022-01-12

No results posted yet for this study

Summary

This article describes a case of successful treatment of a 59-year-old man with sepsis as a result of periprosthetic infection against the background of severe SARS-CoV-2-19, who was hospitalized for 59 days, 57 of which were in the intensive care unit. Vibroacoustic pulmonary therapy, the concept of noninvasive ventilation, syndrome therapy, combination antibiotic therapy taking into account the pathogen and antibiotic sensitivity were used in the treatment.

Conditions

  • SARS CoV 2 Infection

Interventions

DEVICE

vibroacoustic therapy

Vibroacoustic respiratory therapy

Sponsors & Collaborators

  • Astana Medical University

    lead OTHER

Eligibility

Min Age
59 Years
Max Age
59 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2020-11-25
Completion
2021-01-01

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188482 on ClinicalTrials.gov